Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [4934]

AACR 2025: Oral investigational agent zoldonrasib elicits objective responses in patients with KRAS G12D-mutated lung cancer

AACR 2025: Oral investigational agent zoldonrasib elicits objective responses in patients with KRAS G12D-mutated...

Unlocking a new era in liver cancer treatment: The power of neddylation-targeted therapies

Unlocking a new era in liver cancer treatment: The power of neddylation-targeted therapies

Drug dismantles a metabolic barrier to anti-tumour immunity

Drug dismantles a metabolic barrier to anti-tumour immunity

New cell therapy shows promising results in advanced tumour diseases

New cell therapy shows promising results in advanced tumour diseases

Radioiodine therapy improves relative survival rates of differentiated thyroid cancer patients

Radioiodine therapy improves relative survival rates of differentiated thyroid cancer patients

Cancer research reveals how chemo impact cells at the molecular level

Cancer research reveals how chemo impact cells at the molecular level

Study identifies an epigenetic signature with prognostic value in metastatic thyroid cancer

Study identifies an epigenetic signature with prognostic value in metastatic thyroid cancer

Study identifies how malaria can lead to childhood cancer

Study identifies how malaria can lead to childhood cancer

New way to prevent duodenal cancer

New way to prevent duodenal cancer

FDA approves penpulimab-kcqx for non-keratinizing nasopharyngeal carcinoma

FDA approves penpulimab-kcqx for non-keratinizing nasopharyngeal carcinoma

More from ecancer